BioinformaticsbioRxivPreprint
In-silico studies of Riparin B in the design of drugs: Physicochemical, pharmacokinetic and pharmacodynamic parameters
Adriene de Freitas Moreno Rodrigues, Rayla Kelly Magalhães Costa, Ranyelison Silva Machado…·Aldeídia Pereira de Oliveira
This study uses in silico tools to predict the drug-like properties and pharmacokinetic/pharmacodynamic profiles of Riparin B, suggesting its potential as a drug candidate for Alzheimer's disease treatment.